Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 38.4B | 37.9B | 36.2B | 35.7B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 17.2B | 17.6B | 16.6B | 14.9B |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 7.2B | 5.2B | 5.5B | 8.0B |
| Tax provision | 1.8B | 1.3B | 1.4B | 2.0B |
| Net income | 5.3B | 3.8B | 4.0B | 5.9B |
| Basic EPS | — | 4.0 | 4.3 | 6.3 |
| Diluted EPS | — | 4.0 | 4.3 | 6.3 |
| Basic average shares | — | 950.9M | 951.6M | 951.1M |
| Diluted average shares | — | 950.9M | 951.6M | 951.1M |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |